The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma & CLL Hub is an independent medical education platform, sponsored by Beigene, Johnson & Johnson and Roche, and supported through educational grants from Bristol Myers Squibb, Incyte, Lilly, and Pfizer. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View lym content recommended for you
Loretta NastoupilDuring the 2020 Annual Meeting of the Society of Hematologic Oncology (SOHO), the Lymphoma Hub spoke to Loretta Nastoupil, MD Anderson Cancer Center, Houston, US. We asked: What are the chemotherapy-free treatment options for lymphoma?
What are the chemotherapy-free treatment options for lymphoma?
A number of chemotherapy-free approaches have recently been approved by the FDA for the treatment of patients with lymphoma and were the focus of this talk. Loretta Nastoupil highlights that as more novel targeted therapies emerge into the lymphoma setting, chemotherapy will become less involved in the treatment paradigm for patients with lymphoma.